Effect of Prolonged Treatment with Neuroleptics on Dopamine D‐1 and D‐2 Receptor Density in Corpus Striatum of Mice
- 1 November 1986
- journal article
- research article
- Published by Wiley in Acta Pharmacologica et Toxicologica
- Vol. 59 (5) , 387-391
- https://doi.org/10.1111/j.1600-0773.1986.tb00189.x
Abstract
The effects of long-term treatment with neuroleptics on D-1 and D-2 receptor parameters in corpus striatum were studied in mice. Mice were treated daily for 12 days with the selective D-1 antagonist, the benzazepine SCH 23390, the mixed D-1/D-2 antagonist zuclopenthixol or the selective D-2 antagonist haloperidol. Three days after withdrawal Bmax and KD for 3H-SCH 23390 binding to D-1 receptors and 3H-spiperone binding to D-2 receptors were determined. The study showed that the density of D-2 receptors increased after haloperidol whereas no changes were seen after SCH 23390 or zuclopenthixol. No changes in D-1-receptor density were seen after either treatment. The results are in full agreement with published behavioural results where haloperidol induces tolerance whereas SCH 23390 or zuclopenthixol do not. Some changes in KD values were seen. The cause and meaning of these changes await further investigation.Keywords
This publication has 16 references indexed in Scilit:
- The Benzazepine, SCH 23390, Inhibits 3H‐NPA Binding in Mouse Brain In VivoActa Pharmacologica et Toxicologica, 1986
- A comparison between dopamine-stimulated adenylate cyclase and 3H-SCH 23390 binding in rat striatumLife Sciences, 1985
- Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatumLife Sciences, 1984
- Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neurolepticsLife Sciences, 1984
- Persistent increase in striatal dopamine stimulated adenylate cyclase activity persists for more than 6 months but disappears after 1 year following withdrawal from 18 months cis-flupenthixol intakeBiochemical Pharmacology, 1983
- How to analyze binding, enzyme and uptake data: The simplest case, a single phaseLife Sciences, 1982
- Similarities between the binding of 3H-piflutixol and 3H-flupentixol to rat striatal dopamine receptors in vitroLife Sciences, 1981
- Prolonged treatment with the GABA agonist THIP increases dopamine receptor binding more than it changes dopaminergic behaviour in miceDrug Development Research, 1981
- Dopamine-mediated behaviour and 3H-spiperone binding to striatal membranes in rats after nine months haloperidol administrationLife Sciences, 1980
- Antischizophrenic Drugs: Chronic Treatment Elevates Dopamine Receptor Binding in BrainScience, 1977